More Patients With Breast Cancer Can Skip Axillary Dissection Will Pass May 30, 2026

https://www.medscape.com/viewarticle/more-patients-breast-cancer-can-skip-axillary-dissection-2026a1000i1u Women with breast cancer and 1-2 sentinel lymph node macrometastases can safely skip completion axillary lymph node dissection (ALND) without compromising overall survival or arm function, according to new data from the largest randomized trial of its kind to date.